AzTrials
AzTrials

StrokeNCT02858349

Mechanisms of Walking Recovery After Stroke

A study testing High-intensity interval training in people with Stroke, run by University of Cincinnati at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Subjects with stroke will have behavioral testing and brain imaging before and after a 4-week control period and a 4-week exercise intervention. Read more about this study

Who is it for?
Ages 30 to 90 yearsHealthy volunteers can take part
Conditions the study is for
Stroke
What is being tested?
High-intensity interval training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
Jul 2016to Dec 2017
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • age 30-90 years
  • unilateral stroke experienced >6 months prior to enrollment in middle cerebral artery (MCA) territory without complete disruption of the putamen on the lesion side
  • walking speed <= 1.0 m/s on the 10 meter walk test
  • able to walk 10m over ground with assistive devices as needed and no physical assistance

Who cannot join

  • MRI incompatibility (e.g. metallic or electronic implants, severe claustrophobia)
  • inability to perform mental imagery (time dependent motor imagery screening test [TDMI])
  • evidence of significant arrhythmia or myocardial ischemia on treadmill ECG stress test, or significant baseline ECG abnormalities that would make an exercise ECG uninterpretable
  • recent (<3 months) cardiopulmonary hospitalization
  • unable to communicate with investigators or correctly answer consent comprehension questions
  • significant ataxia or neglect (score of 2 on NIH stroke scale item 7 or 11)
Show all 13Show fewer
  • severe lower extremity (LE) spasticity (Ashworth >2)
  • recent (<3 months) illicit drug or alcohol abuse or significant mental illness
  • major post-stroke depression (PHQ-9 ≥10) in the absence of medical management
  • participating in physical therapy or another interventional research study;
  • recent (<3 months) paretic LE botulinum toxin injection
  • concurrent progressive neurologic disorder or other major medical, orthopedic or peripheral vascular conditions that would limit improvement
  • pregnancy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Cincinnati

    Cincinnati, Ohio, 45267

Other trials in United States

About this study

Subjects with stroke will have behavioral testing and brain imaging before and after a 4-week control period and a 4-week exercise intervention.

Read the detailed description

Subjects with stroke will have behavioral testing and brain imaging before and after a 4-week control period and a 4-week exercise intervention using high-intensity interval training.

Conditions
Stroke
Being tested
No intervention, High-intensity interval training
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionBehavioural

    No intervention

  • High-intensity interval trainingBehavioural

    High-intensity walking exercise using bursts of concentrated effort alternated with recovery periods

Study groups in NCT02858349
Study groupRoleWhat they receive
Arm 1Experimental4-week control period with no intervention and 4-weeks of high-intensity interval training
Receives: Behavioral: No intervention; Behavioral: High-intensity interval training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Walking Speed

    10-meter walk test

    Measured: Change from 4-weeks to 8-weeks

Secondary outcomes (11)
  1. Gait Symmetry

    Paretic step ratio

    Measured: baseline, 4 weeks, 8 weeks

  2. Metabolic Cost of Gait

    oxygen consumption rate during comfortable speed gait

    Measured: baseline, 4 weeks, 8 weeks

  3. Aerobic Capacity

    oxygen consumption rate during exercise testing

    Measured: baseline, 4 weeks, 8 weeks

  4. NIH Toolbox - Cognition Domain

    Measured: baseline, 4 weeks, 8 weeks

  5. NIH Toolbox Standing Balance Test

    Measured: baseline, 4 weeks, 8 weeks

  6. Stroke and Aphasia Quality of Life Scale

    Measured: baseline, 4 weeks, 8 weeks

  7. Brain Locomotor Network Activation

    Measured: baseline, 4 weeks, 8 weeks

  8. Brain Locomotor Network Connectivity

    Measured: baseline, 4 weeks, 8 weeks

  9. Walking Capacity

    6-minute walk test

    Measured: baseline, 4 weeks, 8 weeks

  10. Daily Walking Activity

    activity monitor

    Measured: baseline, 4 weeks, 8 weeks

  11. Walking Speed

    10-meter walk test

    Measured: baseline, 4 weeks, 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2016 (estimated)
  2. Study startJul 2016
  3. Primary completionDec 2017
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02858349
Sponsor's protocol ID
2016-1916
Status last verified
Nov 2018
First submitted
29 Jul 2016
Last updated
15 Mar 2019
Data monitoring committee
No
Individual data sharing
No

Publications

  • Foster J, Awosika OO, Boyne P. Longitudinal Changes in the Cortico-Reticulospinal Tract Associated with High-Intensity Locomotor Training in Chronic Stroke. Neurorehabil Neural Repair. 2026 Nov 1:15459683261493916. doi: 10.1177/15459683261493916. Online ahead of print.

    PubMed 42968579
  • Foster J, Awosika OO, Boyne P. Role of Contralesional Corticoreticulospinal Tract Compensation in Walking Function After Stroke. Brain Behav. 2026 Jun;16(6):e71500. doi: 10.1002/brb3.71500.

    PubMed 42204918
  • Foster J, Awosika OO, Boyne P. Longitudinal changes in the cortico-reticulospinal tract associated with high-intensity locomotor training in chronic stroke. medRxiv [Preprint]. 2026 May 15:2026.05.12.26353042. doi: 10.64898/2026.05.12.26353042.

    PubMed 42180339

Questions about this trial

What is this clinical trial studying?

A study testing High-intensity interval training in people with Stroke, run by University of Cincinnati at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 15 Mar 2019). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Walking Speed (time frame: Change from 4-weeks to 8-weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02858349, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in